Phathom Pharmaceuticals (PHAT) Other Operating Expenses (2019)

Phathom Pharmaceuticals (PHAT) reported Other Operating Expenses of $78.9 million for Q2 2019.

Phathom Pharmaceuticals (PHAT) Other Operating Expenses (2019) Analysis & Trends

Phathom Pharmaceuticals (PHAT) has 1 years of Other Operating Expenses data on file, last reported at $78.9 million in Q2 2019.

Other Operating Expenses for Q2 2019 came in at $78.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $78.9 million (changed N/A YoY), and the FY2019 annual result was $78.9 million, changed N/A from the prior year.
Other Operating Expenses steadied at $78.9 million in Q2 2019 per PHAT's latest filing.
Over five years, Other Operating Expenses peaked at $78.9 million in Q2 2019 and troughed at $78.9 million in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Phathom Pharmaceuticals	895.99 Mn	712.23 Mn	46.31 Mn

Download Data

Date	Value
Jun 30, 2019	78.90 Mn